Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. Robert M. Hershberg M.D., Ph.D. |
IPO Date | April 29, 2022 |
Location | United States |
Headquarters | 75 State Street, Boston, MA, United States, 02109 |
Employees | 90 |
Sector | Healthcare |
Industry | Biotechnology |
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
NA
NA
NA
NA
NA
NA
NA
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email